Skip to main content

Correction:Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma

The Original Article was published on 18 June 2024

Correction: Journal of Nanobiotechnology (2024) 22:338 https://doi.org/10.1186/s12951-024-02579-1


In this article the wrong figure appeared as Fig. 6: author corrections in the title of the graph in panel E and in the image in panel H were not implemented due to a typesetting mistake. Figure 6 should have appeared as shown below.


Uncorrected figure

figure a

Corrected figure

Fig. 6
figure 1

Combining BT-NPs@PLEL with anti-PD-L1 treatment for inhibition in residual tumors after iRFA. A Schematic representation of treatment of residual tumor after iRFA in C57/BL6 mice. B Bioluminescence images of mice with residual tumors after iRFA after different treatments on days 0, 10, and 20 (n = 3). C Bioluminescence signals of mice in each group on day 0, 10, and 20 (n = 3). D Tumor volume of residual tumors after iRFA in different groups(n = 6). E The weight of residual tumors on day 21 after different treatments (n = 6). F Survival analysis of experimental mice in different groups (n = 6). G Representative Flow cytometry plots and proportions of CD8+ T cells on day 7 (n = 6). H Representative flow cytometry plots and proportions of Granzyme B+ cells on day 7 (n = 6). ns, not significant *p < 0.05, **p < 0.01, ***p < 0.001

The original article has been corrected. The publisher apologises to the authors and readers for the inconvenience caused by this error.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xi Li, Junjie Mao or Bin Zhou.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, J., Li, X., Chen, J. et al. Correction:Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma. J Nanobiotechnol 22, 462 (2024). https://doi.org/10.1186/s12951-024-02690-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12951-024-02690-3